- Home
- PROF vs ATAI Comparison
PROF vs ATAI Comparison
Compare PROF & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- ATAI
- Stock Information
- Founded
- PROF N/A
- ATAI 2018
- Country
- PROF Canada
- ATAI Germany
- Employees
- PROF N/A
- ATAI N/A
- Industry
- PROF Medical/Dental Instruments
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- ATAI Health Care
- Exchange
- PROF Nasdaq
- ATAI Nasdaq
- Market Cap
- PROF 215.6M
- ATAI 214.8M
- IPO Year
- PROF N/A
- ATAI 2021
- Fundamental
- Price
- PROF $7.15
- ATAI $1.28
- Analyst Decision
- PROF Strong Buy
- ATAI Strong Buy
- Analyst Count
- PROF 2
- ATAI 4
- Target Price
- PROF $11.40
- ATAI $9.00
- AVG Volume (30 Days)
- PROF 117.2K
- ATAI 1.2M
- Earning Date
- PROF 11-07-2024
- ATAI 11-13-2024
- Dividend Yield
- PROF N/A
- ATAI N/A
- EPS Growth
- PROF N/A
- ATAI N/A
- EPS
- PROF N/A
- ATAI N/A
- Revenue
- PROF $8,984,000.00
- ATAI $331,000.00
- Revenue This Year
- PROF $56.61
- ATAI $80.07
- Revenue Next Year
- PROF $160.87
- ATAI N/A
- P/E Ratio
- PROF N/A
- ATAI N/A
- Revenue Growth
- PROF 39.35
- ATAI N/A
- 52 Week Low
- PROF $6.88
- ATAI $1.03
- 52 Week High
- PROF $11.42
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- PROF 41.76
- ATAI 42.84
- Support Level
- PROF $6.89
- ATAI $1.15
- Resistance Level
- PROF $7.28
- ATAI $1.26
- Average True Range (ATR)
- PROF 0.35
- ATAI 0.10
- MACD
- PROF -0.04
- ATAI -0.02
- Stochastic Oscillator
- PROF 25.00
- ATAI 24.07
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.